- Home
- REPL vs MTAL Comparison
REPL vs MTAL Comparison
Compare REPL & MTAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- MTAL
- Stock Information
- Founded
- REPL 2015
- MTAL 2021
- Country
- REPL United States
- MTAL Jersey
- Employees
- REPL 331
- MTAL 3
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- MTAL Blank Checks
- Sector
- REPL Health Care
- MTAL Finance
- Exchange
- REPL Nasdaq
- MTAL Nasdaq
- Market Cap
- REPL 1.1B
- MTAL 886.2M
- IPO Year
- REPL 2018
- MTAL 2021
- Fundamental
- Price
- REPL $13.98
- MTAL $10.75
- Analyst Decision
- REPL Strong Buy
- MTAL Buy
- Analyst Count
- REPL 6
- MTAL 2
- Target Price
- REPL $19.83
- MTAL $14.75
- AVG Volume (30 Days)
- REPL 610.9K
- MTAL 219.7K
- Earning Date
- REPL 02-12-2025
- MTAL 01-01-0001
- Dividend Yield
- REPL N/A
- MTAL N/A
- EPS Growth
- REPL N/A
- MTAL N/A
- EPS
- REPL N/A
- MTAL N/A
- Revenue
- REPL N/A
- MTAL $322,583,000.00
- Revenue This Year
- REPL N/A
- MTAL $126.93
- Revenue Next Year
- REPL $1,065.54
- MTAL $19.58
- P/E Ratio
- REPL N/A
- MTAL N/A
- Revenue Growth
- REPL N/A
- MTAL 1636.56
- 52 Week Low
- REPL $4.92
- MTAL $9.89
- 52 Week High
- REPL $17.00
- MTAL $15.26
- Technical
- Relative Strength Index (RSI)
- REPL 55.54
- MTAL 46.46
- Support Level
- REPL $13.40
- MTAL $10.84
- Resistance Level
- REPL $14.59
- MTAL $11.60
- Average True Range (ATR)
- REPL 0.84
- MTAL 0.34
- MACD
- REPL -0.02
- MTAL 0.03
- Stochastic Oscillator
- REPL 66.52
- MTAL 49.01
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About MTAL Metals Acquisition Limited
MAC Copper Ltd is a company focused on operating and acquiring metals and mining businesses in high-quality, stable jurisdictions that are critical in the electrification and decarbonization of the world-wide economy.